The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation is a new method to estimate glomerular filtration rate (GFR), which is a key indicator of kidney function. This equation was developed to improve accuracy compared to the widely used MDRD Study equation. The CKD-EPI equation was validated using data from multiple studies and the National Health and Nutrition Examination Survey (NHANES), showing better performance, especially at higher GFR values. It has lower bias, improved precision, and greater accuracy in estimating GFR. The CKD-EPI equation is more accurate than the MDRD equation, particularly for GFR greater than 60 mL/min per 1.73 m², and could replace the MDRD equation for clinical use. However, the sample used to develop the equation included a limited number of elderly individuals and racial and ethnic minorities, so further studies are needed in these populations. The CKD-EPI equation is more accurate and could have important implications for public health and clinical practice. It is based on serum creatinine levels, age, sex, and race, and uses a more sophisticated statistical model to account for the relationship between creatinine and GFR. The equation is implemented in clinical laboratories and is recommended for general use. The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases. The CKD-EPI equation is more accurate than the MDRD equation and is recommended for clinical use. The study found that the CKD-EPI equation leads to a lower estimated prevalence of chronic kidney disease compared to the MDRD equation. The equation is more accurate in estimating GFR and has important implications for public health and clinical practice. The study highlights the importance of accurate GFR estimation in clinical practice and public health. The CKD-EPI equation is recommended for general clinical use.The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation is a new method to estimate glomerular filtration rate (GFR), which is a key indicator of kidney function. This equation was developed to improve accuracy compared to the widely used MDRD Study equation. The CKD-EPI equation was validated using data from multiple studies and the National Health and Nutrition Examination Survey (NHANES), showing better performance, especially at higher GFR values. It has lower bias, improved precision, and greater accuracy in estimating GFR. The CKD-EPI equation is more accurate than the MDRD equation, particularly for GFR greater than 60 mL/min per 1.73 m², and could replace the MDRD equation for clinical use. However, the sample used to develop the equation included a limited number of elderly individuals and racial and ethnic minorities, so further studies are needed in these populations. The CKD-EPI equation is more accurate and could have important implications for public health and clinical practice. It is based on serum creatinine levels, age, sex, and race, and uses a more sophisticated statistical model to account for the relationship between creatinine and GFR. The equation is implemented in clinical laboratories and is recommended for general use. The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases. The CKD-EPI equation is more accurate than the MDRD equation and is recommended for clinical use. The study found that the CKD-EPI equation leads to a lower estimated prevalence of chronic kidney disease compared to the MDRD equation. The equation is more accurate in estimating GFR and has important implications for public health and clinical practice. The study highlights the importance of accurate GFR estimation in clinical practice and public health. The CKD-EPI equation is recommended for general clinical use.